Rational Advisors’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Rational Advisors’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-700	Closed	-$57K	–	597
2018 Q1	$57K	Hold	700	–	–	0.03%	280
2017 Q4	$55K	Hold	700	–	–	0.03%	233
2017 Q3	$65K	Hold	700	–	–	0.03%	280
2017 Q2	$79K	Buy	+700	New	+$78.2K	0.05%	237

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

YCMGA

York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Rational Advisors's CBPO Position: Q2 2018 in Review

Rational Advisors sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2018, closing a stake of 700 shares — an estimated $57K sold.

Rational Advisors first reported a position in CBPO in Q2 2017 and held it in 4 quarters. The position peaked at $79K in Q2 2017. 91 funds tracked by Wall St. Rank hold CBPO as of Q2 2018.

Rational Advisors reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2018 after selling out during the quarter.
Rational Advisors sold 700 China Biologic Products Holdings, Inc. shares in Q2 2018, an estimated $57K.
Rational Advisors first reported a position in China Biologic Products Holdings, Inc. in Q2 2017 and held it in 4 quarters.
Rational Advisors's China Biologic Products Holdings, Inc. position peaked at $79K in Q2 2017.
91 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2018.

Based on Rational Advisors's 13F filing for Q2 2018, filed 7 Aug 2018.